Hippocratic AI has seen rapid growth over the past 18 months, inking partnerships with more than 50 large health systems, payers and pharma clients and building 1,000 use cases for its patient-facing healthcare AI agents. The company banked a $126 million series C round, boosting its valuation to $3.5 billion, executives announced Monday. Hippocratic AI has raised $404 million in total funding to date, including a $141 million series B round in January and $53 million in series A funding in March 2024. The company’s valuation following it series B round was $1.64 billion. Avenir Growth led the series C round, along with backing from new and existing investors, including CapitalG (Google’s growth fund), General Catalyst, Andreessen Horowitz (a16z), Kleiner Perkins, Premji Invest, John Doerr, Rick Klausner, and others. Major health systems Universal Health Services and Cincinnati Children’s Hospital Medical Center, along with integrated healthcare system WellSpan Health, also backed Hippocratic AI’s series C round.

Full report : Hippocratic AI, which offers health care AI agents, raised a $126 million Series C led by Avenir at a $3.5 billion valuation, up from $1.64 billion after a $141 million Series B in January 2025.